Revive Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	0.02	0.01	0.77	2.09	3.92	16.6
Cash & Short-Term Investments	0.02	0.01	0.77	2.09	3.92	16.6
Cash Growth	-92.33%	-98.12%	-62.96%	-46.69%	-76.41%	1020.48%
Accounts Receivable	-	-	0.01	0.14	0.11	0.09
Other Receivables	0.01	-	0.01	0.02	0.08	0.03
Receivables	0.01	-	0.02	0.16	0.19	0.13
Prepaid Expenses	0.08	0.04	0.3	0.06	0.06	0.07
Restricted Cash	0.01	0.01	0.05	0.05	-	-
Total Current Assets	0.11	0.07	1.14	2.35	4.16	16.79
Property, Plant & Equipment	0	0	0	0	0	0
Long-Term Investments	0.14	0.14	0.12	0.16	0.25	0.25
Other Intangible Assets	-	-	9.38	11.72	12.5	12.5
Long-Term Accounts Receivable	-	-	-	0.01	0.15	0.26
Total Assets	0.25	0.21	10.64	14.25	17.07	29.81
Accounts Payable	2.76	2.65	2.58	2.66	3.92	0.44
Accrued Expenses	0.84	0.87	0.72	0.64	0.14	0.07
Current Portion of Leases	-	-	0.03	0.13	0.11	0.09
Total Current Liabilities	3.6	3.51	3.32	3.44	4.17	0.6
Long-Term Debt	0.07	0.07	-	0.06	0.06	0.06
Long-Term Leases	-	-	-	0.03	0.16	0.27
Other Long-Term Liabilities	0.08	0.08	0.08	0.08	0.08	0.07
Total Liabilities	3.75	3.66	3.4	3.6	4.46	1
Common Stock	47.86	47.7	47.5	45.98	43.11	42.43
Additional Paid-In Capital	23.69	23.63	23.51	12.66	12.4	11.39
Retained Earnings	-77.48	-77.2	-66.19	-60.57	-54.25	-36.44
Comprehensive Income & Other	2.43	2.41	2.41	12.58	11.34	11.43
Shareholders' Equity	-3.5	-3.46	7.23	10.65	12.6	28.81
Total Liabilities & Equity	0.25	0.21	10.64	14.25	17.07	29.81
Total Debt	0.07	0.07	0.03	0.22	0.33	0.42
Net Cash (Debt)	-0.05	-0.05	0.75	1.87	3.59	16.18
Net Cash Growth	-	-	-59.96%	-47.94%	-77.83%	1493.48%
Net Cash Per Share	-0.00	-0.00	0.00	0.01	0.01	0.06
Filing Date Shares Outstanding	435.68	432.32	418.56	357.65	321.13	317.96
Total Common Shares Outstanding	435.68	425.21	418.56	357.65	321.42	317.96
Working Capital	-3.49	-3.45	-2.18	-1.08	-0	16.2
Book Value Per Share	-0.01	-0.01	0.02	0.03	0.04	0.09
Tangible Book Value	-3.5	-3.46	-2.15	-1.07	0.1	16.31
Tangible Book Value Per Share	-0.01	-0.01	-0.01	-0.00	0.00	0.05
Machinery	0.01	0.01	0.01	0.01	0.01	0.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.